Pancreatic Surgery — MCQs

Pancreatic Surgery Indian Medical PG Practice Questions and MCQs

Question 311: A 58-year-old alcoholic male presents with jaundice and imaging reveals a pancreatic mass. Which of the following factors are MOST important in determining whether this tumor is resectable?

A. Tumor size and invasion
B. Artery involvement and metastasis
C. Metastasis and local invasion (Correct Answer)
D. Patient's overall health and age

Explanation: ***Metastasis and local invasion*** - The presence of **distant metastases** (e.g., to the liver or peritoneum) renders pancreatic cancer unresectable as it indicates widespread disease not curable by surgery. - **Local invasion** of critical structures such as major blood vessels (e.g., superior mesenteric artery, celiac axis) or adjacent organs often makes surgical removal impossible or carries very high risks and poor outcomes. *Tumor size and invasion* - While tumor size can be a factor, a small tumor with **distant metastasis** is unresectable. - The critical aspect of invasion is its extent and involvement of **major vascular structures**, not just its presence. *Artery involvement and metastasis* - While **artery involvement** (especially superior mesenteric artery or celiac axis) is a crucial component of local invasion determining resectability, it's not the sole factor. - **Metastasis** is indeed critical, but this option lists only one specific aspect of local invasion rather than the broader concept of local unresectability. *Patient's overall health and age* - These factors determine **surgical candidacy** (i.e., whether a patient can tolerate surgery), but not necessarily the **technical resectability** of the tumor itself. - A patient may be otherwise healthy, but if the tumor has metastasized or massively invaded local structures, it remains unresectable.

Question 312: A 55-year-old male with chronic pancreatitis presents with a 4 cm pseudocyst causing gastric outlet obstruction. What considerations are essential in deciding between endoscopic drainage and surgical cystogastrostomy?

A. Location and size of the pseudocyst, presence of infection, and patient’s overall condition (Correct Answer)
B. Patient’s age and dietary habits
C. Availability of surgical staff
D. Cost of procedure

Explanation: ***Location and size of the pseudocyst, presence of infection, and patient's overall condition*** - The **location** (proximity to stomach/duodenum) and **size** of the pseudocyst determine accessibility for endoscopic drainage and technical feasibility of surgical approaches - **Presence of infection** significantly influences treatment choice - infected pseudocysts may require more definitive surgical drainage and antibiotics, making endoscopic approach less suitable - The patient's **overall medical condition and comorbidities** (cardiac disease, coagulopathy, nutritional status) are critical in assessing surgical risk versus benefit of less invasive endoscopic procedures - These three factors form the foundation of clinical decision-making between endoscopic and surgical approaches *Patient's age and dietary habits* - While **age** contributes to overall surgical risk assessment, it is not an independent primary determinant for choosing between drainage approaches - **Dietary habits** do not directly influence the technical choice of drainage procedure, though nutritional status affects perioperative outcomes - These factors are secondary considerations, not essential criteria for procedure selection *Availability of surgical staff* - **Staffing availability** is a logistical/administrative consideration that affects scheduling but should not determine the optimal clinical approach - The decision between endoscopic and surgical drainage must be based on patient and pseudocyst characteristics, not resource availability - Clinical indications should drive treatment choice, with appropriate resources then allocated *Cost of procedure* - **Procedure cost** is a healthcare system consideration but must not override clinical appropriateness and patient safety - The choice between endoscopic and surgical drainage should prioritize **clinical efficacy, safety, and long-term outcomes** over financial factors - In management of symptomatic pancreatic pseudocysts causing obstruction, the most clinically appropriate intervention takes precedence

Question 313: What is a key feature of the Whipple procedure?

A. Splenectomy is performed
B. Resection of the entire pancreas
C. Removal of the pancreatic head is performed (Correct Answer)
D. Partial hepatectomy is involved

Explanation: ***Removal of the pancreatic head is performed*** - The **Whipple procedure**, also known as pancreaticoduodenectomy, involves the **surgical removal of the head of the pancreas**. - It also includes removal of the **duodenum**, gallbladder, and a portion of the bile duct, often performed for **pancreatic head cancer**. *Resection of the entire pancreas* - This describes a **total pancreatectomy**, which is a more extensive procedure than the Whipple. - A total pancreatectomy is typically reserved for diffuse pancreatic disease or multifocal tumors, contrasting with the Whipple's focus on the **pancreatic head**. *Splenectomy is performed* - **Splenectomy** is generally not part of the standard Whipple procedure, as the spleen is anatomically distant and not typically involved. - However, in cases of malignancy involving the splenic vessels or tail of the pancreas, a **distal pancreatectomy with splenectomy** might be performed, but this is a different operation. *Partial hepatectomy is involved* - A **partial hepatectomy** is the removal of a portion of the liver and is not a component of the standard Whipple procedure. - Liver resection would only be performed if there were **liver metastases** or direct invasion, which would usually contraindicate a curative Whipple.

Question 314: In a patient with locally advanced pancreatic cancer, what factors should be considered to decide between immediate surgery and neoadjuvant chemotherapy?

A. Patient's age and treatment preference.
B. Presence of comorbidities and performance status.
C. Tumor biology and response to previous treatments.
D. Tumor resectability, potential for margin-negative resection, and patient's overall health status. (Correct Answer)

Explanation: ***Tumor resectability, potential for margin-negative resection, and patient's overall health status.*** - This is the **most comprehensive answer** as it includes all three critical domains for decision-making in locally advanced pancreatic cancer. - **Resectability status** (borderline resectable vs locally advanced unresectable) is the primary determinant—only borderline resectable tumors are typically considered for either immediate surgery or neoadjuvant therapy. - **Potential for R0 resection (margin-negative)** indicates the likelihood of complete tumor removal without microscopic residual disease, which significantly impacts survival. - **Patient's overall health status** encompasses functional status, comorbidities, nutritional state, and ability to tolerate major surgery—all essential for treatment selection. *Presence of comorbidities and performance status.* - While these factors are **absolutely crucial** in the decision-making process, they represent only **one component** of the comprehensive assessment needed. - This option addresses patient fitness but **omits the oncological factors** (tumor resectability and margin status) that are equally essential in determining treatment strategy. - The correct answer includes these factors within "overall health status" while also incorporating the critical tumor-related factors. *Patient's age and treatment preference.* - Patient preference is important for **shared decision-making** and respecting autonomy, but must be informed by medical evidence about resectability and treatment feasibility. - Age alone is **not a reliable predictor** of surgical outcomes—functional status and comorbidity burden are more important than chronological age. - These factors are **secondary considerations** after establishing the oncological appropriateness of each treatment approach. *Tumor biology and response to previous treatments.* - **Tumor biology** (CA19-9 levels, genetic mutations, tumor grade) is increasingly recognized in treatment planning but is typically more relevant for **prognosis** than for the initial surgery-versus-neoadjuvant decision. - **Response to previous treatments** is only applicable if the patient has already received therapy, which would not be the case for initial treatment planning in newly diagnosed locally advanced disease. - The primary decision still hinges on **anatomical resectability** rather than molecular characteristics, though this is evolving with precision medicine.

Question 315: A 55-year-old man presents with painless jaundice and a palpable gallbladder. A CT scan shows a mass in the head of the pancreas. What is the next step in management?

A. ERCP with biopsy
B. Laparoscopic cholecystectomy
C. Percutaneous liver biopsy
D. MRI of the pancreas (Correct Answer)

Explanation: ***MRI of the pancreas*** - The presentation of **painless jaundice** with a **palpable gallbladder (Courvoisier's sign)** and a pancreatic head mass on CT strongly suggests **pancreatic head malignancy**. - While CT has identified the mass, **MRI/MRCP provides superior assessment** of the biliary tree, vascular involvement, and tumor resectability, which are **critical for surgical planning**. - **High-quality cross-sectional imaging** is the essential next step before considering biopsy or intervention, as it determines whether the patient is a candidate for potentially curative resection. - Modern practice emphasizes that **potentially resectable pancreatic cancer may proceed to surgery without pre-operative biopsy**, making complete staging the priority. *ERCP with biopsy* - While ERCP can provide biliary drainage for symptomatic relief, **ERCP biopsy has poor sensitivity** for pancreatic malignancy and is **not the preferred method** for tissue diagnosis. - If tissue diagnosis is required (e.g., for borderline resectable disease requiring neoadjuvant therapy), **EUS-FNA (endoscopic ultrasound with fine needle aspiration)** is superior to ERCP biopsy. - ERCP should be reserved for **biliary decompression** when needed, not as a primary diagnostic tool for pancreatic masses. *Laparoscopic cholecystectomy* - Cholecystectomy treats gallbladder pathology but does **not address the underlying pancreatic head mass** causing biliary obstruction. - The palpable gallbladder is a **sign of distal biliary obstruction** from the pancreatic mass, not primary gallbladder disease requiring removal. *Percutaneous liver biopsy* - A liver biopsy would only be appropriate if **liver metastases** were suspected and needed confirmation for staging. - It does not provide diagnosis of the **primary pancreatic mass**, which is the immediate concern for treatment planning.

Question 316: A patient with severe pancreatitis develops a necrotizing infection of the pancreatic bed. What is the most appropriate intervention?

A. Broad-spectrum antibiotics and IV fluids
B. Endoscopic retrograde cholangiopancreatography (ERCP)
C. Total pancreatectomy
D. Surgical debridement after stabilization or step-up approach (Correct Answer)

Explanation: ***Surgical debridement after stabilization or step-up approach*** - For **necrotizing pancreatitis** with infection, the most appropriate intervention involves **surgical debridement** of the necrotic tissue. This is often performed after the patient has been stabilized, following a **step-up approach** (percutaneous drainage followed by deferred minimally invasive necrosectomy if needed). - This approach aims to minimize systemic inflammatory response and allows for a more targeted debridement once the demarcation between viable and necrotic tissue is clear. *Broad-spectrum antibiotics and IV fluids* - While **broad-spectrum antibiotics** are crucial for treating infected necrosis, they are typically used as an adjunct to debridement, not as a standalone definitive treatment. - **IV fluids** are essential for supportive care in severe pancreatitis but do not resolve the infected necrotic tissue itself. *Endoscopic retrograde cholangiopancreatography (ERCP)* - **ERCP** is indicated in pancreatitis primarily for the removal of **choledocholithiasis** when there is **biliary obstruction** or **cholangitis**, which is not the primary issue described (necrotizing infection). - It does not address the infected pancreatic necrosis directly and is not a treatment for this specific complication. *Total pancreatectomy* - **Total pancreatectomy** is an extreme measure with significant morbidity and mortality, usually reserved for severe cases of **pancreatic cancer** or extensive, unstoppable bleeding, not typically for infected necrosis alone. - The goal in necrotizing pancreatitis is debridement of necrotic tissue, not removal of the entire healthy or salvageable pancreas.

Question 317: In a 48-year-old male with chronic pancreatitis presenting with severe epigastric pain and weight loss, and a CT scan showing a 3 cm pancreatic head mass with questionable superior mesenteric vein involvement, which management strategy is preferred?

A. Endoscopic ultrasound-guided biopsy to confirm malignancy before considering surgery. (Correct Answer)
B. Direct surgical resection without prior biopsy.
C. Observation with follow-up imaging only.
D. Initiate chemotherapy immediately.

Explanation: ***Endoscopic ultrasound-guided biopsy to confirm malignancy before considering surgery.*** - An EUS-guided biopsy is crucial to definitively diagnose malignancy in a patient with a pancreatic mass, especially with a history of **chronic pancreatitis**, which can mimic cancer. - This approach allows for **histopathological confirmation** before proceeding with potentially morbid surgery, informing subsequent treatment decisions (e.g., neoadjuvant therapy). *Direct surgical resection without prior biopsy.* - Performing complex pancreatic surgery without a **confirmed diagnosis of malignancy** carries significant risks, including unnecessary surgery for benign conditions such as inflammatory masses from chronic pancreatitis. - A definitive diagnosis guides the surgical approach and ensures that the patient benefits from the procedure, avoiding **unwarranted morbidity and mortality**. *Observation with follow-up imaging only.* - Given the patient's severe symptoms (**epigastric pain, weight loss**) and the presence of a **pancreatic mass** on CT, observation alone is inappropriate and risks delaying diagnosis and treatment of a potentially curable cancer. - This approach would be suitable for **small, asymptomatic cysts** or incidental findings without high-risk features, which is not the case here. *Initiate chemotherapy immediately.* - Initiating chemotherapy without a **histological diagnosis** of malignancy is inappropriate and could lead to unnecessary treatment with significant side effects for a benign condition. - Chemotherapy is typically reserved for **confirmed malignancies**, either as neoadjuvant/adjuvant therapy or for unresectable disease.

Question 318: A 70-year-old male is scheduled for a Whipple procedure for pancreatic cancer. What is a key preoperative consideration?

A. Cardiopulmonary evaluation (Correct Answer)
B. Nutritional assessment
C. Intraoperative biopsy
D. Prophylactic antibiotics

Explanation: ***Cardiopulmonary evaluation*** - Preoperative **cardiopulmonary evaluation** is crucial for a **70-year-old patient** undergoing a **Whipple procedure** (pancreaticoduodenectomy), which is one of the most complex and physiologically demanding abdominal surgeries. - This assessment identifies **cardiac risk factors** (coronary artery disease, heart failure, arrhythmias) and **pulmonary issues** (COPD, restrictive lung disease) that could lead to perioperative complications or death. - Advanced age significantly increases the risk of **postoperative cardiopulmonary complications**, making this evaluation essential for risk stratification and optimization. *Nutritional assessment* - **Nutritional assessment** is also a critical preoperative consideration in pancreatic cancer patients, as they frequently have **malnutrition, weight loss, and obstructive jaundice**. - Preoperative nutritional optimization (enteral nutrition, correction of albumin, vitamin K supplementation) improves surgical outcomes and wound healing. - However, in the context of a **70-year-old patient**, cardiopulmonary evaluation takes precedence for immediate risk assessment, though both evaluations are important. *Intraoperative biopsy* - An **intraoperative biopsy** is not a preoperative consideration; it may be performed during surgery if diagnosis is uncertain or to assess resection margins. - Pancreatic cancer diagnosis is typically established preoperatively through **CT imaging and endoscopic ultrasound-guided FNA**. *Prophylactic antibiotics* - **Prophylactic antibiotics** are administered perioperatively (within 60 minutes before incision) to prevent surgical site infections. - This is a standard intraoperative protocol rather than a preoperative evaluation or consideration for patient optimization.

Question 319: A 55-year-old male presents with jaundice and weight loss. Imaging reveals a mass at the head of the pancreas. Which structure is most likely to be compressed?

A. Common bile duct (Correct Answer)
B. Duodenum
C. Portal vein
D. Superior mesenteric artery

Explanation: **Correct Answer: Common bile duct** - A mass in the **head of the pancreas** is strategically located to compress the **common bile duct**, which passes directly through or just behind it. - Compression of the common bile duct leads to **obstructive jaundice**, a hallmark symptom consistent with the patient's presentation. - This is the classic presentation of **pancreatic head carcinoma**, often associated with **painless progressive jaundice** and a **palpable gallbladder** (Courvoisier's sign). *Incorrect: Duodenum* - While the duodenum wraps around the head of the pancreas (C-loop), direct compression causing **jaundice** is less common than common bile duct obstruction. - Significant duodenal compression would typically lead to symptoms like **gastric outlet obstruction** (nausea, vomiting, early satiety), which are not the primary presentation here. *Incorrect: Portal vein* - The **portal vein** runs posterior to the head of the pancreas, and while it can be involved in advanced pancreatic cancer, its compression is less common as the primary cause of isolated jaundice. - Compression of the portal vein would primarily lead to **portal hypertension**, potentially causing symptoms like splenomegaly, ascites, or varices, not direct jaundice. *Incorrect: Superior mesenteric artery* - The **superior mesenteric artery (SMA)** originates from the aorta and runs anterior to the uncinate process of the pancreas but is not typically compressed by a pancreatic head mass in a way that causes jaundice. - Compression or involvement of the SMA would more likely cause **mesenteric ischemia** if severe, presenting with abdominal pain or indicating unresectability of the tumor, not jaundice.

Question 320: What is the best approach for optimizing patient outcomes in resectable pancreatic head cancer?

A. Conduct minimal preoperative assessments to expedite the process.
B. Rely exclusively on surgical techniques without input from other specialties.
C. Emphasize the speed of surgery rather than thoroughness.
D. Utilize a multidisciplinary team for planning, ensure careful intraoperative technique, and provide comprehensive postoperative care. (Correct Answer)

Explanation: ***Utilize a multidisciplinary team for planning, ensure careful intraoperative technique, and provide comprehensive postoperative care.*** - A **multidisciplinary approach** involving surgeons, oncologists, radiologists, and gastroenterologists is crucial for optimal planning and management of pancreatic head cancer. - **Careful intraoperative technique** minimizes complications, while comprehensive **postoperative care** manages recovery and supports long-term outcomes, addressing potential challenges like adjuvant therapy and nutritional support. *Conduct minimal preoperative assessments to expedite the process.* - **Minimal preoperative assessment** can lead to missed comorbidities or an incomplete understanding of tumor extent, increasing the risk of surgical complications and suboptimal outcomes. - A thorough workup is necessary to accurately stage the disease, assess resectability, and optimize the patient’s health before a major operation. *Rely exclusively on surgical techniques without input from other specialties.* - This approach limits the benefit of **multimodal therapy**, such as neoadjuvant chemotherapy or radiation, which can improve resectability and survival in certain cases. - **Excluding other specialties** deprives the patient of comprehensive care that addresses all aspects of cancer management, including medical oncology, radiation oncology, and supportive care. *Emphasize the speed of surgery rather than thoroughness.* - Prioritizing **speed over thoroughness** can compromise the quality of resection, potentially leaving behind microscopic disease (positive margins) or increasing the risk of surgical complications. - **Thorough surgical technique**, including meticulous dissection and careful anastomoses, is vital for achieving an R0 resection and minimizing morbidity.

Practice by Chapter

Pancreatic Anatomy and Physiology

Practice Questions

Acute Pancreatitis

Practice Questions

Chronic Pancreatitis

Practice Questions

Pancreatic Pseudocysts

Practice Questions

Pancreatic Adenocarcinoma

Practice Questions

Cystic Neoplasms of Pancreas

Practice Questions

Neuroendocrine Tumors of Pancreas

Practice Questions

Pancreatic Trauma

Practice Questions

Pancreatectomy Techniques

Practice Questions

Whipple Procedure

Practice Questions

Pancreatic Anastomosis

Practice Questions

Complications of Pancreatic Surgery

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free